Emerging landscape of oncogenic signatures across human cancers.
about
Mutational profiling of kinases in glioblastoma.The landscape of long noncoding RNAs in the human transcriptomeJARID1B is a luminal lineage-driving oncogene in breast cancerTrial Watch: Targeting ATM-CHK2 and ATR-CHK1 pathways for anticancer therapyQuantitative Trait Loci Identify Functional Noncoding Variation in CancerGenomic and epigenomic heterogeneity in molecular subtypes of gastric cancerβ1 Integrins as Therapeutic Targets to Disrupt Hallmarks of CancerTreatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine TrialsTranslating cancer genomes and transcriptomes for precision oncologyThe Tip of the Iceberg: Clinical Implications of Genomic Sequencing Projects in Head and Neck CancerRethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancerChallenges of deciphering gastric cancer heterogeneityCurrent and future molecular profiling of cancer by next-generation sequencingNext-generation sequencing: hype and hope for development of personalized radiation therapy?Inferring Pairwise Interactions from Biological Data Using Maximum-Entropy Probability ModelsNot All Next Generation Sequencing Diagnostics are Created Equal: Understanding the Nuances of Solid Tumor Assay Design for Somatic Mutation DetectionRB1: a prototype tumor suppressor and an enigmaIntegrative analysis of cancer imaging readouts by networksOligodendroglioma: pathology, molecular mechanisms and markersSciClone: inferring clonal architecture and tracking the spatial and temporal patterns of tumor evolutionDNA methylation changes in epithelial ovarian cancer histotypes.Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas.The possibility of clinical sequencing in the management of cancerNarrowing the focus: a toolkit to systematically connect oncogenic signaling pathways with cancer phenotypesThe Emergence of Pan-Cancer CIMP and Its Elusive InterpretationUsing Pharmacogenomic Databases for Discovering Patient-Target Genes and Small Molecule Candidates to Cancer TherapyMolecular pathways: novel approaches for improved therapeutic targeting of Hedgehog signaling in cancer stem cellsAppraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breastThe mutational landscape of endometrial cancerExonuclease mutations in DNA polymerase epsilon reveal replication strand specific mutation patterns and human origins of replicationHypermutation in human cancer genomes: footprints and mechanismsComprehensive genomic characterization of head and neck squamous cell carcinomasComprehensive Molecular Portraits of Invasive Lobular Breast CancerThe somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapesSurveying Recent Themes in Translational Bioinformatics: Big Data in EHRs, Omics for Drugs, and Personal GenomicsDiscovery of Drug Synergies in Gastric Cancer Cells Predicted by Logical ModelingA Pan-Cancer Catalogue of Cancer Driver Protein Interaction InterfacesEGFR Activation Leads to Cell Death Independent of PI3K/AKT/mTOR in an AD293 Cell LineTumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid ClassesEfficient and simple approach to in vitro culture of primary epithelial cancer cells
P2860
Q21261249-802C2397-ADF5-4415-8690-EF881E33E7D8Q22122065-CBE7764A-96B9-412F-9CA4-AAE0A8B82311Q24299326-43F3DF81-80F1-481C-A7EE-DC359DD0C56DQ26745686-EC0CD04B-0C77-49E2-8B0D-AF54995EB2D0Q26764745-55B5E3FA-1FE9-4E27-906E-F3EE35A03573Q26774509-CE285870-24D6-4A96-A490-81C34124AB41Q26774789-939DAC95-53EA-447A-B143-B18C31EEAF94Q26776394-1F45DD47-419F-4156-84F1-7069312C1733Q26777081-F339E7C5-D9B2-4697-8DD8-DAA2E83BD431Q26778433-5B518A7F-69D9-4675-8C62-E6A380F3A342Q26780387-280B84BD-6EE0-43D0-B62D-E208C32A9479Q26784448-A5E46E33-6EAC-44C4-9BEA-EE580C47FB7AQ26796272-79A3B11C-7867-4708-816E-71FD54CF9B75Q26796485-B17ADAB8-E1B5-4CA4-B85F-48F5C2086D6BQ26801539-1D94D493-AA66-47FC-A4F9-D48A79A49B02Q26801745-6D9F29CD-A2E1-45F9-8717-762ED5294FB0Q26866393-F2A2A918-5222-43D8-A331-51C7C95EA4B0Q26999069-CD48D9B3-1CA6-478D-BACD-35C672F98916Q27002448-A4BE43A6-688B-4D01-BC34-9F9618B4E64BQ27321859-47E12B5A-020C-4260-B1E5-A84ABA783480Q27690722-CAABC2FB-24E8-420B-8D15-B7A40BA53A1AQ27853175-812B6035-CFE1-4D21-B809-DDF20677D2F5Q28072144-7EEAF6CF-79C4-4C2A-A147-10ADA3111480Q28072745-39532927-FC78-4298-B1F3-D884D8372AAEQ28075374-BE82A070-2E21-435A-86A1-AF4658AEBFF5Q28076097-401309AC-360B-410F-835D-182CF9CB9228Q28081405-069DFA9C-E492-4C67-B5E4-FE9037FCCE5BQ28083103-25CB8D2C-AF41-4E26-8FD0-1EDA65009153Q28084466-FCCD3C48-50DF-4118-9489-64B6C8475ABDQ28248149-2B9BA133-EF2D-47D0-AE77-41EC8EAA7E2FQ28255066-2F537EE0-1AD6-4836-B1FF-56BA15EBFECDQ28256121-24B2BE65-FA2C-413C-BC41-DC6E9FD6841AQ28268284-92A8834F-0619-4266-A81C-624035C3608AQ28275430-BF77F786-8DC3-4F5F-8B57-38F5F09D0F3DQ28542977-4AE335D9-AC8D-4836-97DA-8EA88B087417Q28547862-CDE79B99-641C-45A5-811B-5F389774636AQ28550391-A8BF70F2-1110-4240-B49E-F2587CCFBA29Q28551853-9C761AEA-DE2B-4B84-B681-1B20320F72A9Q28554412-16060C03-A9A4-43E3-B4E2-D4A09D3800D1Q28588419-DC9C3246-4806-4A6B-B1C2-2E7428F1C960
P2860
Emerging landscape of oncogenic signatures across human cancers.
description
2013 nî lūn-bûn
@nan
2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Emerging landscape of oncogenic signatures across human cancers.
@ast
Emerging landscape of oncogenic signatures across human cancers.
@en
type
label
Emerging landscape of oncogenic signatures across human cancers.
@ast
Emerging landscape of oncogenic signatures across human cancers.
@en
prefLabel
Emerging landscape of oncogenic signatures across human cancers.
@ast
Emerging landscape of oncogenic signatures across human cancers.
@en
P2860
P50
P356
P1433
P1476
Emerging landscape of oncogenic signatures across human cancers.
@en
P2093
Chris Sander
P2860
P2888
P304
P356
10.1038/NG.2762
P407
P577
2013-10-01T00:00:00Z